The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index; 1 of the 6 sources its claims cite were checked for support.
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man
Open accessAbstract
The steady-state basal plasma glucose and insulin concentrations are determined by their interaction in a feedback loop. A computer-solved model has been used to predict the homeostatic concentrations which arise from varying degrees beta-cell deficiency and insulin resistance. Comparison of a patient's fasting values with the model's predictions allows a quantitative assessment of the contributions of insulin resistance and deficient beta-cell function to the fasting hyperglycaemia (homeostasis model assessment, HOMA). The accuracy and precision of the estimate have been determined by comparison with independent measures of insulin resistance and beta-cell function using hyperglycaemic and euglycaemic clamps and an intravenous glucose tolerance test. The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (Rs = 0.88, p less than 0.0001), the fasting insulin concentration (Rs = 0.81, p less than 0.0001), and the hyperglycaemic clamp, (Rs = 0.69, p less than 0.01). There was no correlation with any aspect of insulin-receptor binding. The estimate of deficient beta-cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (Rs = 0.61, p less than 0.01) and with the estimate from the intravenous glucose tolerance test (Rs = 0.64, p less than 0.05). The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for beta-cell deficit) limits its use, but the correlation of the model's estimates with patient data accords with the hypothesis that basal glucose and insulin interactions are largely determined by a simple feed back loop.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
15 Own result · 7 Own interpretation · 3 No full text of the sources · 1 Partly supported · 1 No basis given · accuracy not yet measured
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The fasting plasma insulin concentration is largely determined by the glucose concentration [3]”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
What the sources say
- Partly supportedcites [3] McCarthy ST, Harris F, Turner RC (1977) Glucose control of basal insulin secretion in diabetes. Diabetologia 13: 93?97 sourceExperimental — accuracy not yet measured
The Results and Discussion (page unavailable in our copy) show that changing plasma glucose affects basal insulin secretion. But they also report markedly impaired responses in diabetic subjects, including cases where insulin remained nearly constant despite a substantial glucose decrease. The paper therefore supports glucose as an influence, but not the unqualified claim that it largely determines fasting insulin concentration. (LLM, conf=0.84)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of deficient/3cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (R~ = 0.61, p< 0.01)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (R~=0.88,p<0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was no correlation with any aspect of insulin-receptor binding.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the fasting insulin concentration (P~ = 0.81, p < 0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 32%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Reproducibility of estimate of /3-cell function by HOMA
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“in both groups together (1% 0.61, p < 0.01 : Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Comparisons of methods of assessing ~3-cell function
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and with the estimate from the intravenous glucose tolerance test (R~ = 0.64, p < 0.05).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and in both groups together: 1% = 0.64, p< 0.05; Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with intravenous glucose tolerance test.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Neither receptor numbers or any aspect of high or low affinity binding correlated with other measures of insulin resistance (HOMA, clamp, basal insulin or CIGMA: ~ all < 0.55; NS).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
- It may state two separate claims as one. 2
- The quote only partly states this claim. 1
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for/3-cell deficit) limits its use”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 31%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Hyperglycaemic clamp : ~-cell function (%)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The quote only partly states this claim.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The degree of the hyperglycaemia does not correlate significantly with either the degrees of abnormal fl-cell function or insulin resistance.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Discussion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The authors state this as an assumption.
Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
“Assuming that normal-weight normal subjects aged < 35 years have 100% r-cell function, and an insulin resistance of 1, the values for a patient can be assessed from the insulin and glucose concentrations by the formulae: r-cell”
The paper relies on this without support.
The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
“The plasma glucose:insulin response for normal subjects, equivalent to the C-peptide response, is insulin = 5 (glucose-3.5).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Surrogate markers of peripheral insulin activity, such as homeostasis model assessment and whole-body insulin sensitivity indexes, could be useful as well in the early identification of patients with IR, before overt DM sets in ().”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [240]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“After the unprocessed diet, fasting glucose and insulin levels tended to decrease compared to baseline and the homeostasis model assessment of insulin resistance (HOMA-IR) (Matthews et al., 1985) was significantly decreased compared to baseline.”
From Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized Controlled Trial of Ad Libitum Food Intake (2019) · cites this paper as Matthews et al., 1985
The cited source says what the claim attributes to it.
In the citing paper
“The Homeostasis Model Assessment of Insulin Resistance (HoMA-IR) was calculated according to Matthews et al. [25].”
From Chronotype: A Tool to Screen Eating Habits in Polycystic Ovary Syndrome? (2022) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“AAV9-mTERT treated mice also showed a trend for an improved glucose uptake and a better homeostatic model assessment (HOMA (Heikkinen et al, 2007; Matthews et al, 1985)) compared to the AAV9-eGFP controls, although differences did not reach statistical significance (Supporting Information Fig S4D and E).”
From Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer (2012) · cites this paper as Matthews et al, 1985
In the citing paper
“ndirect estimates of insulin resistance, such as HOMA-IR 63 and QUICKI, 64 are derived from fasting S-insulin and glucose concentrations and have been widely used in both nondiabetic and type 2 diabetic subjects as surrogates of insulin sensitivity.65,66”
From Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. (2008) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Subjects and procedures
“The same 12 normal subjects and 11 Type 2 diabetic patients came to the hospital fasting on a separate day for a continuous infusion”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
“HOMA compared with CIGMA.The HOMA estimate of insulin resistance from the mean of 15 stressed fasting samples before the CIGMA correlated with that measured by CIGMA in 11 normal subjects (R~ = 0.69, p < 0.02), in 12 diabetic subjects (R~ 0.97, p < 0.0001)”
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Quantitative estimation of insulin sensitivity.
Bergman, R. N., Ider, Y. Z., Bowden, C. R., & Cobelli, C. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.6.e667 · Cited by 1,874 · cited 1×
“This use of modelling to provide a reference graph contrasts with other models where an individual patient's data have to be entered into a computer to determine the relationships between rapidly changing variables, such as occur after an intravenous glucose test [19].”
Method[WHO Expert Committee on diabetes mellitus].
Reitsma, W. D., & Terpstra, J. (1981) · PubMed · Cited by 556
Turner, R. C., Holman, R. R., Matthews, D., Hockaday, T. D. R., & Peto, J. (1979) · Metabolism · doi:10.1016/0026-0495(79)90146-x · Cited by 388
Self-citationCharacteristics of Human Erythrocyte Insulin Receptors
Gambhir, K. K., Archer, J. A., & BRADLEY, C. J. (1978) · Diabetes · doi:10.2337/diab.27.7.701 · Cited by 290
The Insulin Receptor: Its Role in Insulin Resistance of Obesity and Diabetes
Olefsky, J. M. (1976) · Diabetes · doi:10.2337/diab.25.12.1154 · Cited by 289
Hosker, J. P., Matthews, D. R., Rudenski, A. S., Burnett, M. A., Darling, P., Bown, E. G., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280882 · Cited by 287
Self-citationPulsatile Insulin Has Greater Hypoglycemic Effect Than Continuous Delivery
Matthews, D. R., Naylor, B. A., Jones, R., Ward, G. M., & Turner, R. C. (1983) · Diabetes · doi:10.2337/diab.32.7.617 · Cited by 256
Self-citationControl of pulsatile insulin secretion in man
Matthews, D. R., Lang, D. A., Burnett, M. A., & Turner, R. C. (1983) · Diabetologia · doi:10.1007/bf00282705 · Cited by 175
Self-citationTHE BASAL PLASMA GLUCOSE: A SIMPLE RELEVANT INDEX OF MATURITY‐ONSET DIABETES
HOLMAN, R. R., & TURNER, R. C. (1981) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1981.tb00196.x · Cited by 64
Self-citation
Research works printed but not linked: 2
- Metropolitan Life Assurance Co (1959) Net weight standard for men and women. Stat Bull Metrol Life Found 40: 1?4
- Matthews DR, Hosker JP (1984) An unbiased, flexible computer programme for glucose clamping, with graphics and running statistics. Diabetologia 27: 308?309 A
Cited by
Sorted by citations
Items 9,901–10,000 of 31,469
Bohl, M., Bjørnshave, A., Larsen, M. K., Gregersen, S., & Hermansen, K. (2016) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2016.207 · Cited by 50
Arias, M., Iruzubieta, P., Puente, Á., Ramos, D., Cruz, C. S., Estébanez, Á., Llerena, S., Alonso-Martín, C., Segundo, D. S., Álvarez, L., et al. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17111878 · Cited by 36
Association of a gain‐of‐function variant in LGR4 with central obesity
Zou, Y., Ning, T., Shi, J., Chen, M., Ding, L., Huang, Y. F., Kauderer, S., Xu, M., Cui, B., Bi, Y., et al. (2016) · Obesity · doi:10.1002/oby.21704 · Cited by 36
Szostaczuk, N., Priego, T., Palou, M., Palou, A., & Picó, C. (2016) · International Journal of Obesity · doi:10.1038/ijo.2016.241 · Cited by 36
Rice bran protein hydrolysates attenuate diabetic nephropathy in diabetic animal model
Boonloh, K., Lee, E. S., Kim, H. M., et al. (2016) · European Journal of Nutrition · doi:10.1007/s00394-016-1366-y · Cited by 36
Oliveira, S. R., Kallaur, A. P., Lopes, J. M., Simão, A. N. C., Reiche, E. M. V., de Almeida, E. R. D., Morimoto, H. K., Pereira, W. L. D. C. J., Alfieri, D. F., Flauzino, T., et al. (2016) · Psychiatry Research · doi:10.1016/j.psychres.2016.12.039 · Cited by 37
Correlation of insulin resistance and motor function in spinal and bulbar muscular atrophy
Nakatsuji, H., Araki, A., Hashizume, A., Hijikata, Y., Yamada, S., Inagaki, T., Suzuki, K., Banno, H., Suga, N., Okada, Y., et al. (2017) · Journal of Neurology · doi:10.1007/s00415-017-8405-3 · Cited by 37
Wang, J., Kim, B. S., Han, K., & Kim, H. (2017) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph14060555 · Cited by 36
Borai, I. H., Shaker, Y., Kamal, M. M., Ezzat, W. M., Ashour, E., Afify, M., Gouda, W., & Elbrashy, M. M. (2017) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2017.00004 · Cited by 36
García‐Carrizo, F., Priego, T., Szostaczuk, N., Palou, A., & Picó, C. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00445 · Cited by 37
de Andrade, A. M., Fernandes, M. D. C., de Fraga, L. S., Porawski, M., Giovenardi, M., & Guedes, R. P. (2017) · Metabolic Brain Disease · doi:10.1007/s11011-017-0080-7 · Cited by 39
Jahansouz, C., Xu, H., Hertzel, A. V., Kizy, S., Steen, K. A., Foncea, R. E., Serrot, F. J., Kvalheim, N., Luthra, G., Ewing, K., et al. (2017) · International Journal of Obesity · doi:10.1038/ijo.2017.197 · Cited by 40
Feng, J., Guo, Y., Ma, L., Xing, J., Sun, R., & Zhu, W. (2017) · Journal of Cosmetic Dermatology · doi:10.1111/jocd.12387 · Cited by 36
Predictors of transitions in frailty severity and mortality among people aging with HIV
Brothers, T. D., Kirkland, S., Theou, O., Zona, S., Malagoli, A., Wallace, L. M. K., Stentarelli, C., Mussini, C., Falutz, J., Guaraldi, G., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0185352 · Cited by 38
Ferjan, S., Janež, A., & Jensterle, M. (2017) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2017.0095 · Cited by 36
High intake of orange juice and cola differently affects metabolic risk in healthy subjects
Büsing, F., Hägele, F. A., Nas, A., Döbert, L.-V., Fricker, A. M., Dörner, E., Podlesny, D., Aschoff, J. K., Pöhnl, T., Schweiggert, R. M., et al. (2018) · Clinical Nutrition · doi:10.1016/j.clnu.2018.02.028 · Cited by 39
Nishikawa, T., Ono, K., Hashimoto, S., Kinoshita, H., Watanabe, T., Araki, H., Otsu, K., Sakamoto, W., Harada, M., Toyonaga, T., et al. (2018) · Journal of Diabetes Investigation · doi:10.1111/jdi.12848 · Cited by 33
Climie, R. E., Grace, M. S., Larsen, R. N., Dempsey, P. C., Oberoi, J., Cohen, N. D., Owen, N. G., Kingwell, B. A., & Dunstan, D. W. (2018) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2018.05.009 · Cited by 34
Schwenger, K. J. P., Fischer, S. E., Jackson, T., Okrainec, A., & Allard, J. P. (2018) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2018.06.007 · Cited by 36
Bonnet, F., Tavenard, A., Esvan, M., Laviolle, B., Viltard, M., Lepicard, E. M., & Lainé, F. (2018) · Journal of Nutrition · doi:10.1093/jn/nxy100 · Cited by 36
Polycystic Ovary Syndrome and Hyperandrogenic States
Chang, R. J., & Dumesic, D. A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-47912-7.00021-4 · Cited by 41
Reda, E., Hassaneen, S. K., & El-Abhar, H. S. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00771 · Cited by 35
Mosqueda-Solís, A., Sánchez, J., Reynés, B., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-32875-4 · Cited by 36
Type 2 diabetes is causally associated with depression: a Mendelian randomization analysis
Xuan, L., Zhao, Z., Xu, J. Y., Hou, Y., Wang, T., Li, M., Lu, J., Xu, Y., Chen, Y., Qi, L., et al. (2018) · Frontiers of Medicine · doi:10.1007/s11684-018-0671-7 · Cited by 34
Sadeghi, F., Salehi, S., Kohanmoo, A., & Akhlaghi, M. (2019) · International Journal of Preventive Medicine · doi:10.4103/ijpvm.ijpvm_109_18 · Cited by 37
Costa, E. S., França, C. N., Fonseca, F. A. H., Kato, J. T., Bianco, H. T., de Freitas, T. T., Fonseca, H. A. R., Neto, A. M. F., & Izar, M. C. D. O. (2019) · British Journal Of Nutrition · doi:10.1017/s0007114519000576 · Cited by 41
HIV disease, metabolic dysfunction and atherosclerosis: A three year prospective study
Low, H., Hoang, A., Pushkarsky, T., Dubrovsky, L., Dewar, E. M., Yacovo, M. S. D., Mukhamedova, N., Cheng, L., Downs, C., Simon, G. L., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0215620 · Cited by 36
Shida, T., Oshida, N., Oh, S., Okada, K., & Shoda, J. (2019) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s185705 · Cited by 36
Association of non-alcoholic fatty liver disease with microvascular complications of type 2 diabetes
Afarideh, M., Aryan, Z., Ghajar, A., et al. (2019) · Primary care diabetes · doi:10.1016/j.pcd.2019.03.009 · Cited by 36
High HOMA-IR Index in Healthcare Shift Workers
Ledda, C., Cinà, D., Matera, S., Mucci, N., Bracci, M., & Rapisarda, V. (2019) · Medicina · doi:10.3390/medicina55050186 · Cited by 37
Davis, R., Bonham, M. P., Nguo, K., & Huggins, C. E. (2019) · Clinical Nutrition · doi:10.1016/j.clnu.2019.06.014 · Cited by 39
Hołowko, J., Michalczyk, M. M., Zając, A., Czerwińska-Rogowska, M., Ryterská, K., Banaszczak, M., Jakubczyk, K., & Stachowska, E. (2019) · Nutrients · doi:10.3390/nu11071461 · Cited by 36
Darand, M., Darabi, Z., Yari, Z., Hedayati, M., Shahrbaf, M. A., Khoncheh, A., Ahangar, B. H., Alavian, S. M., & Hekmatdoost, A. (2019) · Phytotherapy Research · doi:10.1002/ptr.6424 · Cited by 36
Lin, P., Chang, C.-C., Wu, K., Shih, C., Chiang, W., Chen, H.-Y., Shih, Y.-H., Wang, K.-L., Hong, Y., Shieh, T., et al. (2019) · Biomolecules · doi:10.3390/biom9080327 · Cited by 36
Wibæk, R., Vistisen, D., Girma, T., Admassu, B., Abera, M., Abdissa, A., Jørgensen, M. E., Kæstel, P., Michaelsen, K. F., Friis, H., et al. (2019) · PLoS Medicine · doi:10.1371/journal.pmed.1002888 · Cited by 35
Reijrink, M., de Boer, S. A., Spoor, D. S., Lefrandt, J. D., Heerspink, H. J. L., Boellaard, R., Greuter, M. J. W., Borra, R., Hillebrands, J., Slart, R. H. J. A., et al. (2019) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2019.09.016 · Cited by 36
Kornetova, E. G., Корнетов, А. Н., Mednova, I. A., Dubrovskaya, V. V., Boiko, A. S., Bokhan, N. A., LOONEN, A. J. M., & Ivanova, S. А. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00803 · Cited by 41
Matias, L. L. R., Costa, R. O., Passos, T. S., et al. (2019) · Nutrients · doi:10.3390/nu11112770 · Cited by 36
Sleep characteristics and white matter hyperintensities among midlife women
Thurston, R. C., Wu, M., Aizenstein, H. J., Chang, Y., Barinas‐Mitchell, E., Derby, C. A., & Maki, P. M. (2019) · SLEEP · doi:10.1093/sleep/zsz298 · Cited by 37
Fontanelli, M. D. M., Micha, R., Sales, C. H., Liu, J., Mozaffarian, D., & Fisberg, R. M. (2019) · European Journal of Nutrition · doi:10.1007/s00394-019-02165-4 · Cited by 40
Elenkova, A. P., Matrozova, J., Vasilev, V., Robeva, R. N., & Zacharieva, S. (2020) · Annales d Endocrinologie · doi:10.1016/j.ando.2020.01.001 · Cited by 36
Siddiqi, S. M., Sun, C., Wu, X., Shah, I., & Mehmood, A. (2020) · BioMed Research International · doi:10.1155/2020/8058463 · Cited by 36
The underlying mechanism of metabolic syndrome on benign prostatic hyperplasia and prostate volume
Xia, B., Zhao, S., Chen, Z., Chen, C., Liu, T., Yang, F., & Yan, Y. (2020) · The Prostate · doi:10.1002/pros.23962 · Cited by 39
Sánchez‐García, A., Rodríguez‐Gutiérrez, R., Saldívar‐Rodríguez, D., Guzmán‐López, A., Castillo-Castro, C., Mancillas‐Adame, L. G., Santos-Santillana, K. M., González‐Nava, V., & González‐González, J. G. (2020) · Gynecological Endocrinology · doi:10.1080/09513590.2020.1742687 · Cited by 37
Tan, M. J., Lamendola, C. A., Luong, R., McLaughlin, T., & Craig, C. M. (2020) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14048 · Cited by 38
El-Derany, M. O., & El‐Demerdash, E. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.113942 · Cited by 36
Greenwood, E. A., Pasch, L. A., Cedars, M. I., & Huddleston, H. G. (2020) · Fertility and Sterility · doi:10.1016/j.fertnstert.2020.01.016 · Cited by 38
Liu, P. J., Liu, Y.-P., Ma, L., Yao, A. M., Chen, X. Y., Hou, Y. X., Wu, L., & Xia, L. Y. (2020) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s250279 · Cited by 41
Poessel, M., Freiherr, J., Wiencke, K., Villringer, A., & Horstmann, A. (2020) · Nutrients · doi:10.3390/nu12082201 · Cited by 39
Adamska, A., Łebkowska, A., Krentowska, A., Hryniewicka, J., Adamski, M., Leśniewska, M., Polak, A. M., & Kowalska, I. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00440 · Cited by 35
van Rooijen, M. A., Plat, J., Blom, W. A. M., Zock, P. L., & Mensink, R. P. (2020) · Clinical Nutrition · doi:10.1016/j.clnu.2020.08.016 · Cited by 38
Duft, R. G., Castro, A., Bonfante, I. L. P., Lopes, W. A., da Silva, L. R., Chacon‐Mikahil, M. P. T., Leite, N., & Cavaglieri, C. R. (2020) · Scientific Reports · doi:10.1038/s41598-020-73943-y · Cited by 36
Rajan, T., Umapathy, D., Ali, D., Kesavan, R., & Ramkumar, K. M. (2020) · Biomolecules · doi:10.3390/biom10101466 · Cited by 37
Serum zinc level and hepatic fibrosis in patients with nonalcoholic fatty liver disease
Kim, M. C., Lee, J. I., Kim, J. H., Kim, H. J., Cho, Y. K., Jeon, W. K., Kim, B. I., & Sohn, W. (2020) · PLoS ONE · doi:10.1371/journal.pone.0240195 · Cited by 36
Zhang, K., Pan, H., Wang, L., Yang, H., Zhu, H., & Gong, F. (2021) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s291350 · Cited by 36
Irisin Has a Protective Role against Osteoporosis in Ovariectomized Rats
Morgan, E. N., Alsharidah, A. S., Mousa, A., & Edrees, H. M. (2021) · BioMed Research International · doi:10.1155/2021/5570229 · Cited by 37
Moderate Caloric Restriction Partially Improved Oxidative Stress Markers in Obese Humans
Kanikowska, D., Kanikowska, A., Swora-Cwynar, E., Grzymislawski, M. B., Sato, M., Bręborowicz, A., Witowski, J., & Korybalska, K. (2021) · Antioxidants · doi:10.3390/antiox10071018 · Cited by 42
Urinary peptidomic profiles to address age-related disabilities: a prospective population study
Martens, D. S., Thijs, L., Latosińska, A., Trenson, S., Siwy, J., Zhang, Z.-Y., Wang, C., Beige, J., Vlahou, A., Janssens, S. P., et al. (2021) · The Lancet Healthy Longevity · doi:10.1016/s2666-7568(21)00226-9 · Cited by 35
Mohammadi, A., Bijeh, N., Moazzami, M., Khodaei, K., & Rahimi, N. (2021) · Biological Research For Nursing · doi:10.1177/10998004211050596 · Cited by 36
COVID-19 Outcome Relates With Circulating BDNF, According to Patient Adiposity and Age
Minuzzi, L. G., Seelaender, M. C. L., Silva, B. S. D. A., Cunha, E. D. B. B., Deus, M. D. C., Vasconcellos, F. F., Marqueze, L. F., Gadotti, A. C., Baena, C. P., Pereira, T. S., et al. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.784429 · Cited by 36
Obesity-Related Insulin Resistance: The Central Role of Adipose Tissue Dysfunction
Mocciaro, G., & Gastaldelli, A. (2022) · Handbook of experimental pharmacology · doi:10.1007/164_2021_573 · Cited by 37
MOTS-c and Exercise Restore Cardiac Function by Activating of NRG1-ErbB Signaling in Diabetic Rats
Li, S., Wang, M., Ma, J., Pang, X., Yuan, J., Pan, Y., Fu, Y., & Laher, I. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.812032 · Cited by 36
Cheng, J., Luo, Y., Li, Y., Zhang, F., Zhang, X., Zhou, X., & Ji, L. (2022) · Nutrition & Metabolism · doi:10.1186/s12986-022-00689-x · Cited by 41
Mei, Y., Li, A., Zhao, J., Zhou, Q., Zhao, M., Xu, J., Li, R., Li, Y., Li, K., Ge, X., et al. (2022) · Environmental Research · doi:10.1016/j.envres.2022.114472 · Cited by 36
Harada, N., Hamasaki, A., Yamane, S., Muraoka, A., Joo, E., Fujita, K., & Inagaki, N. (2010) · Journal of Diabetes Investigation · doi:10.1111/j.2040-1124.2010.00078.x · Cited by 36
Depression and Its Comorbid Conditions More Serious in Women than in Men in the United States
Kim, W. K., Shin, D., & Song, W. O. (2015) · Journal of Women s Health · doi:10.1089/jwh.2014.4919 · Cited by 39
Leptin as well as Free Leptin Receptor Is Associated with Polycystic Ovary Syndrome in Young Women
Rizk, N. M., & Sharif, E. (2015) · International Journal of Endocrinology · doi:10.1155/2015/927805 · Cited by 36
Bulcun, E., Ekici, M. S., & Ekici, A. B. (2011) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2011.02795.x · Cited by 35
Singhal, N., Misra, A., Shah, P., Gulati, S., Bhatt, S., Sharma, S., & Pandey, R. M. (2010) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2010.0094 · Cited by 36
Association between serum uric acid and the Adult Treatment Panel III–defined metabolic syndrome:
Rho, Y. H., Woo, J.-H., Choi, S. J., et al. (2007) · Metabolism · doi:10.1016/j.metabol.2007.08.008 · Cited by 36
Echocardiographic alterations in patients with non-functioning adrenal incidentaloma
Ermetici, F., Dall’Asta, C., Malavazos, A. E., Coman, C., Morricone, L. F., Montericcio, V., & Ambrosi, B. (2008) · Journal of Endocrinological Investigation · doi:10.1007/bf03346410 · Cited by 36
Adipose tissue resistin levels in patients with anorexia nervosa
Dostálová, I., Kunešová, M., Duskova, J., Papežová, H., & Nedvidkova, J. (2006) · Nutrition · doi:10.1016/j.nut.2006.06.006 · Cited by 36
Robinson, D. M., Martin, N., Robinson, L. E., Ahmadi, L., Marangoni, A. G., & Wright, A. J. (2008) · Lipids · doi:10.1007/s11745-008-3253-7 · Cited by 36
Cypryk, K., Vilsbøll, T., Nadel, I., Smyczyńska, J., Holst, J. J., & Lewiñski, A. (2007) · Gynecological Endocrinology · doi:10.1080/09513590601137004 · Cited by 36
Independent Effect of Visceral Adipose Tissue on Metabolic Syndrome in Obese Adolescents
Druet, C., Baltakse, V., Chevenne, D., et al. (2008) · Hormone Research in Paediatrics · doi:10.1159/000129674 · Cited by 36
Vogel, C. I. G., Boes, T., Reinehr, T., Roth, C. L., Scherag, S., Scherag, A., Hebebrand, J., & Hinney, A. (2011) · Obesity Facts · doi:10.1159/000324557 · Cited by 36
Bo, S., Gambino, R., Gentile, L., Pagano, G., Rosato, R., Saracco, G. M., Cassader, M., Durazzo, M., & Cavallo‐Perin, P. (2008) · Journal of Hypertension · doi:10.1097/hjh.0b013e328317a7bb · Cited by 35
Peeters, R. P., van der Deure, W. M., van den Beld, A. W., van Toor, H., Lamberts, S. W. J., Janssen, J. A. M. J. L., Uitterlinden, A. G., & Visser, T. J. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.02817.x · Cited by 36
Ardiansyah, A., Shirakawa, H., Koseki, T., Hashizume, K., & Komai, M. (2007) · British Journal Of Nutrition · doi:10.1017/s000711450721013x · Cited by 36
Bortolasci, C. C., Vargas, H. O., Nunes, S. O. V., de Melo, de Castro, M. R. P., Moreira, E. G., Dodd, S., Barbosa, D. S., Berk, M., & Maes, M. H. J. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.03.041 · Cited by 36
AMPK and Insulin Action - Responses to Ageing and High Fat Diet
Frøsig, C., Jensen, T. E., Jeppesen, J. F., Pehmøller, C. K., Treebak, J. T., Maarbjerg, S., Kristensen, J. M., Sylow, L., Alsted, T. J., Schjerling, P., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062338 · Cited by 35
Heart energy metabolism impairment in Western-diet induced obese mice
Neves, F. A., Cortez, E. A. C., Bernardo, A. F., de Mattos, A. B. M., Vieira, A. K. G., Malafaia, T. D. O., Thole, A. A., Rodrigues-Cunha, A. C. D. S., Garcia‐Souza, É. P., Sichieri, R., et al. (2013) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2013.08.014 · Cited by 40
Cardiometabolic Risk in US Army Recruits and the Effects of Basic Combat Training
Pasiakos, S. M., Karl, J. P., Lutz, L. J., Murphy, N. E., Margolis, L. M., Rood, J. C., Cable, S. J., Williams, K. W., Young, A., & McClung, J. P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031222 · Cited by 38
Imamura, M., Iwata, M., Maegawa, H., Watada, H., Hirose, H., Tanaka, Y., Tobe, K., Kaku, K., Kashiwagi, A., Kawamori, R., et al. (2011) · Diabetologia · doi:10.1007/s00125-011-2293-3 · Cited by 35
Hazley, L., Ingle, L., Tsakirides, C., Carroll, S., & Nagi, D. K. (2010) · Research in Sports Medicine · doi:10.1080/15438627.2010.510049 · Cited by 36
Kurył, T., Krejpcio, Z., Wójciak, R. W., Lipko, M. A., Dębski, B., & Staniek, H. (2006) · Biological Trace Element Research · doi:10.1385/bter:114:1:237 · Cited by 36
High Plasma Level of Interleukin-18 in HIV-Infected Subjects With Lipodystrophy
Lindegaard, B., Hansen, A. E., Gerstoft, J., & Pedersen, B. K. (2004) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200405010-00006 · Cited by 36
Comparison of orlistat treatment and placebo in obese type 2 diabetic patients
Derosa, G., Maffioli, P., SALVADEO, S. A. T., Ferrari, I., Gravina, A., Mereu, R., D’Angelo, A., Fogari, E., Palumbo, I., Randazzo, S., et al. (2010) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2010.493557 · Cited by 37
Caixàs, A., Tirado, R., Vendrell, J. J., Gallart, L., Megía, A., Simón, I., Llauradó, G., González‐Clemente, J. M., & Giménez‐Palop, O. (2009) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2009.03546.x · Cited by 36
Wiklund, P., Alén, M., Munukka, E., Cheng, S. M., Yu, B., Pekkala, S., & Cheng, S. (2014) · Journal of sport and health science/Journal of Sport and Health Science · doi:10.1016/j.jshs.2014.03.013 · Cited by 42
Seasonal variations of insulin sensitivity from a euglycemic insulin clamp in elderly men
Berglund, L., Berne, C., Svärdsudd, K., Garmo, H., Melhus, H., & Zethelius, B. (2011) · Upsala Journal of Medical Sciences · doi:10.3109/03009734.2011.628422 · Cited by 36
Hajer, G. R., van der Graaf, Y., Olijhoek, J. K., Edlinger, M., & Visseren, F. L. J. (2007) · American Heart Journal · doi:10.1016/j.ahj.2007.07.013 · Cited by 36
Cho, A. H., Killeya‐Jones, L. A., O’Daniel, J. M., Kawamoto, K., Gallagher, P., Haga, S. B., Lucas, J. E., Trujillo, G., Joy, S. V., & Ginsburg, G. S. (2012) · BMC Health Services Research · doi:10.1186/1472-6963-12-16 · Cited by 39
Antioxidant and anti-inflammatory effects of Urtica pilulifera extracts in type2 diabetic rats
Abo–Elmatty, D. M., Essawy, S. S., Badr, J. M., & Sterner, O. (2012) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2012.11.002 · Cited by 36
Rune, A., Salehzadeh, F., Szekeres, F. L. M., Kühn, I., Osler, M. E., & Al‐Khalili, L. (2009) · Acta Physiologica · doi:10.1111/j.1748-1716.2009.02010.x · Cited by 37
Smith, S. M., Anderson, S. D., Wen, S., et al. (2009) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.29.10.1157 · Cited by 36
Impact of randomized antiretroviral therapy initiation on glucose metabolism
Erlandson, K. M., Kitch, D. W., Tierney, C., Sax, P. E., Daar, E. S., Melbourne, K. M., Ha, B., & McComsey, G. A. (2014) · AIDS · doi:10.1097/qad.0000000000000266 · Cited by 36
Engberg, S., Glümer, C., Witte, D. R., Jørgensen, T., & Borch‐Johnsen, K. (2009) · Diabetologia · doi:10.1007/s00125-009-1587-1 · Cited by 35
The correlation among QTc interval, hyperglycaemia and the impaired autonomic activity
Fiorentini, A., Perciaccante, A., Valente, R., Paris, A., Serra, P., & Tubani, L. (2009) · Autonomic Neuroscience · doi:10.1016/j.autneu.2009.11.006 · Cited by 36
Lin, J. J., Reilly, M. P., Terembula, K., & Wilson, F. P. (2014) · PLoS ONE · doi:10.1371/journal.pone.0114397 · Cited by 36
Metadata
- Authors
- Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C.
- Affiliations
- University of Oxford (GB)
- ORCID
- Matthews, D. R.
- Venue
- Diabetologia
- Published
- 1985-07
- Volume
- 28
- Issue
- 7
- Pages
- 412-419
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2160234571
- Cited by
- 31,502
- References
- 21
- Citations by year
- 2026: 933 · 2025: 1060 · 2024: 1240 · 2023: 1291 · 2022: 1489 · 2021: 1528 · 2020: 1424 · 2019: 1427 · 2018: 1456 · 2017: 1440 · 2016: 1481 · 2015: 1682 · 2014: 1693 · 2013: 1621 · 2012: 1518
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- HOMA, insulin resistance, beta-cell function, fasting blood glucose, fasting insulin, hyperglycaemic clamp, euglycaemic clamp, intravenous glucose tolerance test, insulin receptor binding, type 2 diabetes
- MeSH terms
- Adult, Blood Glucose, Computers, Diabetes Mellitus, Type 2, Erythrocytes, Fasting, Homeostasis, Humans, Insulin, Insulin Resistance, Islets of Langerhans, Middle Aged, Monocytes, Receptor, Insulin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-14, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-14 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
